Literature DB >> 24219277

The epigenetic potentials of dietary polyphenols in prostate cancer management.

Ata Abbas1, William Patterson, Philippe T Georgel.   

Abstract

Prostate cancer is a disease that is greatly affected by lifestyle, particularly diet, and is more prevalent in US and European countries compared with South and East Asia. Among several known causes and risk factors, nutrition plays an important role in prostate cancer pathogenesis. Various dietary components including polyphenols have been shown to possess anticancer properties. Dietary polyphenols have been the subject of extensive studies for the last decade because of their anticancer and chemopreventive potentials. Besides possessing various antitumor properties, dietary polyphenols also contribute to epigenetic changes associated with the fate of cancer cells and have emerged as potential drugs for therapeutic intervention. Various polyphenols have been shown to affect DNA methylation, histone posttranslational modifications, and microRNA expression patterns in prostate cancer. In this review, we discuss the contribution of dietary polyphenols to various epigenetic modifications in prostate cancer. Since prostate cancer and diet are intimately associated, polyphenol-rich diets that epigenetically modify tumor biology have great significance in the prevention and management of prostate cancer.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 24219277     DOI: 10.1139/bcb-2012-0044

Source DB:  PubMed          Journal:  Biochem Cell Biol        ISSN: 0829-8211            Impact factor:   3.626


  8 in total

1.  Epigenetic reactivation of RASSF1A by phenethyl isothiocyanate (PEITC) and promotion of apoptosis in LNCaP cells.

Authors:  Sarandeep S S Boyanapalli; Wenji Li; Francisco Fuentes; Yue Guo; Christina N Ramirez; Ximena-Parades Gonzalez; Douglas Pung; Ah-Ng Tony Kong
Journal:  Pharmacol Res       Date:  2016-11-03       Impact factor: 7.658

2.  Selecting bioactive phenolic compounds as potential agents to inhibit proliferation and VEGF expression in human ovarian cancer cells.

Authors:  Zhiping He; Bo Li; Gary O Rankin; Yon Rojanasakul; Yi Charlie Chen
Journal:  Oncol Lett       Date:  2014-12-22       Impact factor: 2.967

3.  MTA1-Dependent Anticancer Activity of Gnetin C in Prostate Cancer.

Authors:  Avinash Kumar; Kshiti Dholakia; Gabriela Sikorska; Luis A Martinez; Anait S Levenson
Journal:  Nutrients       Date:  2019-09-04       Impact factor: 5.717

4.  Epigenetic Reprogramming Mediated by Maternal Diet Rich in Omega-3 Fatty Acids Protects From Breast Cancer Development in F1 Offspring.

Authors:  Ata Abbas; Theodore Witte; William L Patterson; Johannes F Fahrmann; Kai Guo; Junguk Hur; W Elaine Hardman; Philippe T Georgel
Journal:  Front Cell Dev Biol       Date:  2021-06-10

5.  Gallic acid, a phenolic compound, exerts anti-angiogenic effects via the PTEN/AKT/HIF-1α/VEGF signaling pathway in ovarian cancer cells.

Authors:  Zhiping He; Allen Y Chen; Yon Rojanasakul; Gary O Rankin; Yi Charlie Chen
Journal:  Oncol Rep       Date:  2015-10-27       Impact factor: 3.906

Review 6.  Metabolic syndrome and prostatic disease: potentially role of polyphenols in preventive strategies. A review.

Authors:  Tommaso Castelli; Giorgio Ivan Russo; Giulio Reale; Salvatore Privitera; Mario Chisari; Eugenia Fragalà; Vincenzo Favilla; Sebastiano Cimino; Giuseppe Morgia
Journal:  Int Braz J Urol       Date:  2016 May-Jun       Impact factor: 1.541

7.  A dietary phytochemical alters caste-associated gene expression in honey bees.

Authors:  Wenfu Mao; Mary A Schuler; May R Berenbaum
Journal:  Sci Adv       Date:  2015-08-28       Impact factor: 14.136

8.  Targeting MTA1/HIF-1α signaling by pterostilbene in combination with histone deacetylase inhibitor attenuates prostate cancer progression.

Authors:  Nasir A Butt; Avinash Kumar; Swati Dhar; Agnes M Rimando; Israh Akhtar; John C Hancock; Janice M Lage; Charles R Pound; Jack R Lewin; Christian R Gomez; Anait S Levenson
Journal:  Cancer Med       Date:  2017-10-10       Impact factor: 4.452

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.